Is It Too Late To Reconsider American Healthcare REIT (AHR) After The Recent Pullback

• For investors wondering whether American Healthcare REIT at around US$47.94 still offers value or if most of the upside is already on the table, this article breaks down what the current price might be implying.
• The stock has pulled back with an 8.8% decline over the past week and a 9.0% decline over the past month, following a 65.0% return over the last year and a 1.5% return year to date.
• Recent attention on healthcare real estate and American Healthcare REIT's position in that space has kept the stock in focus for investors looking at income and asset-backed plays. This backdrop helps explain why some are reassessing both the risk profile and the price they are willing to pay.
• On Simply Wall St's valuation checks, American Healthcare REIT scores 3 out of 6 for potential undervaluation, as shown by its valuation score. The next sections will walk through those valuation methods before finishing with a broader way to think about what the market might be pricing in.

American Healthcare REIT delivered 65.0% returns over the last year. See how this stacks up to the rest of the Health Care REITs industry.

Approach 1: American Healthcare REIT Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model estimates what a company might be worth by projecting its future adjusted funds from operations and then discounting those cash flows back to today’s value.

For American Healthcare REIT, the model uses last twelve months free cash flow of about $293.3 million and a two stage forecast that extends out to 2035. Analyst estimates provide figures through 2030, with projected free cash flow of $632.3 million in that year, and Simply Wall St extrapolates further years beyond the analyst horizon.

Pulling all those projected cash flows together, the DCF output suggests an intrinsic value of about $89.83 per share. Compared with the recent share price around $47.94, this output implies a 46.6% discount relative to this model’s estimate of underlying value.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests American Healthcare REIT is undervalued by 46.6%. Track this in your watchlist or portfolio, or discover 55 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for American Healthcare REIT.

Approach 2: American Healthcare REIT Price vs Earnings

For profitable companies, the P/E ratio is a useful way to think about what you are paying for each dollar of current earnings, which is why it is the preferred multiple here. A higher P/E usually reflects higher growth expectations or a perception of lower risk, while a lower P/E can point to lower expected growth or higher perceived risk.

American Healthcare REIT currently trades on a P/E of 129.13x. That sits well above the Health Care REITs industry average P/E of 22.09x and above the peer group average of 62.23x. Simply Wall St’s Fair Ratio for the stock is 45.66x. This represents the P/E that might be expected given factors such as its earnings profile, industry, profit margins, market cap and risk characteristics.

The Fair Ratio is intended to be more tailored than a simple comparison with peers or the broad industry, because it incorporates company specific drivers rather than assuming all REITs in the sector deserve the same multiple. Setting the current P/E of 129.13x against the Fair Ratio of 45.66x points to the shares trading above that modelled range. This suggests the stock screens as overvalued on this metric.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your American Healthcare REIT Narrative

Earlier it was mentioned that there is an even better way to think about valuation, and that is through Narratives. Narratives let you set out your own story for American Healthcare REIT by linking your assumptions about future revenue, earnings and margins to a financial forecast. This can then be turned into a fair value that can be compared with the current price, all within an easy tool on Simply Wall St's Community page that updates when new news or earnings arrive. One investor might build a more optimistic Narrative that lines up with the analyst fair value of about US$58.08, while another might prefer a more cautious Narrative that sits closer to the current share price of about US$47.94. This approach gives each investor a clear, numbers based way to decide whether the stock fits their view.

Do you think there's more to the story for American Healthcare REIT? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com